The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Spiolto Respimat

2.5/2.5 µg/µg Inhalation vapour, solution

IMED Healthcare Ltd.DPR1463/047/001

Main Information

Trade NameSpiolto Respimat
Active SubstancesTiotropium bromide monohydrate
Olodaterol hydrochloride
Strength2.5/2.5 µg/µg
Dosage FormInhalation vapour, solution
Licence HolderIMED Healthcare Ltd.
Licence NumberDPR1463/047/001

Group Information

ATC Code

Status

Authorised/WithdrawnAuthorised
Licence Issued11/06/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsNo document available
Package LeafletNo document available
Public Assessment ReportNo document available
« Back